What is Chemed's D&A?

Chemed (CHE) reported D&A of $16.87M in Q1 2026.

How has Chemed's D&A changed year-over-year?

Chemed's D&A increased by 5.3% year-over-year, from $16.02M to $16.87M.

What is the long-term trend for Chemed's D&A?

Over 4 years (2021 to 2025), Chemed's D&A has grown at a 2.4% compound annual growth rate (CAGR), from $59.05M to $64.84M.

Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Chemed CHE D&A

D&A at other companies

HCA HealthcareHCA

$930M+8.1%

Segments

By segment

See full

Segment Roto Rooter$8.3M+1.5%

Segment Vitas$5.91M+13.8%

Other financials

Income statement

See full

Revenue$657.5M+1.6%

Gross profit$215.8M-0.3%

Operating income$84.6M-10.7%

Net income$66.3M-7.6%

EPS (diluted)$4.84-0.4%

Balance sheet

See full

Cash & equivalents$16.9M-90.3%

Total debt$236.9M+63.3%

Total equity$848.0M-28.2%

Total assets$1.5B-11.0%

Cash flow

See full

Operating cash flow$88.2M+169%

CapEx$17.1M+28.9%

Free cash flow$71.1M+265%

Valuation

See full

Market cap$5.79B-42.3%

Enterprise value$6.01B-39.6%

P/E22.3×-10.2×

P/S2.3×-1.8×

Profitability

See full

Gross margin32.4%-2.4pp

Operating margin12.9%-2.7pp

Net margin10.2%-2.2pp

FCF margin14.8%+2.2pp

Returns & leverage

See full

Return on equity25.6%-0.5pp

Debt / equity0.3×+0.2×

Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Chemed's D&A?: Chemed (CHE) reported D&A of $16.87M in Q1 2026.
How has Chemed's D&A changed year-over-year?: Chemed's D&A increased by 5.3% year-over-year, from $16.02M to $16.87M.
What is the long-term trend for Chemed's D&A?: Over 4 years (2021 to 2025), Chemed's D&A has grown at a 2.4% compound annual growth rate (CAGR), from $59.05M to $64.84M.
What does D&A mean?: Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.